Renaissance Technologies’s Allena Pharmaceuticals ALNA Stock Holding History

Renaissance Technologies’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,200	Closed	-$3K	–	4569
2022 Q2	$3K	Buy	+17,200	New	+$2.66K	﹤0.01%	4173
2021 Q4	–	Sell	-132,700	Closed	-$120K	–	4340
2021 Q3	$120K	Sell	132,700 -567,901	-81%	-$556K	﹤0.01%	3294
2021 Q2	$911K	Buy	700,601 +214,671	+44%	+$260K	﹤0.01%	2711
2021 Q1	$675K	Buy	485,930 +238,919	+97%	+$398K	﹤0.01%	2789
2020 Q4	$316K	Buy	+247,011	New	+$344K	﹤0.01%	3015
2020 Q3	–	Sell	-617,270	Closed	-$975K	–	3802
2020 Q2	$975K	Buy	617,270 +215,492	+54%	+$362K	﹤0.01%	2552
2020 Q1	$387K	Buy	401,778 +160,078	+66%	+$320K	﹤0.01%	2881
2019 Q4	$660K	Buy	241,700 +115,300	+91%	+$379K	﹤0.01%	2796
2019 Q3	$498K	Buy	126,400 +50,200	+66%	+$215K	﹤0.01%	2869
2019 Q2	$310K	Buy	76,200 +61,400	+415%	+$335K	﹤0.01%	3165
2019 Q1	$104K	Buy	+14,800	New	+$107K	﹤0.01%	3296

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies's ALNA Position: Q3 2022 in Review

Renaissance Technologies sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 17,200 shares — an estimated $3K sold.

Renaissance Technologies first reported a position in ALNA in Q1 2019 and held it in 11 quarters. The position peaked at $975K in Q2 2020. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Renaissance Technologies reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Renaissance Technologies sold 17,200 Allena Pharmaceuticals shares in Q3 2022, an estimated $3K.
Renaissance Technologies first reported a position in Allena Pharmaceuticals in Q1 2019 and held it in 11 quarters.
Renaissance Technologies's Allena Pharmaceuticals position peaked at $975K in Q2 2020.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.